The global active pharmaceutical ingredients (API) market is expected to
reach a value of USD 239.8 billion by 2025, based on a new report by Grand View
Research, Inc. The rising prevalence of lifestyle-induced & age-related
diseases and cancer is projected to drive the market over the forecast period.
Advancements in recombinant molecular technologies and high capitalization for
development of novel drugs are also estimated to boost growth.
 |
U.S. API market, by type of synthesis, 2014 - 2025 (USD Billion)
|
Favorable government initiatives for increasing focus toward generic
drugs is a key factor for market growth. Decrease in generic drug prices,
higher acceptance in low income and decrease in reimbursement for branded drugs
are the recent trends in the market affirming growth of generic drugs.
In depth research report on Active
Pharmaceutical Ingredients (API) Market
Further Key Findings from the Study Suggest:
·
Synthetic APIs
was the largest segment by revenue share in 2015 owing to high demand.
·
Biotech APIs
are estimated to grow lucratively over the forecast period with high R&D
initiatives being undertaken for their development
·
Captive
manufacturers, being the conventional option of API manufacturing, held the
majority of the share.
·
On the other
hand, the merchant manufacturers segment is expected to be fastest-growing due
to growing outsourcing activities
·
Generic APIs
will experience lucrative growth over the forecast period attributed to patent
expirations of branded drugs
·
APIs are
identified to have highest application in cardiovascular therapeutics.
Increasing mortality caused by heart diseases and growing demand for
fast-acting drugs are the major factors contributing to dominance
·
North America
dominated in terms of revenue share in 2015 and Asia Pacific is expected to
grow at a significant growth rate over the forecast period
·
Some of the
major companies in the API market are AbbVie, Inc., Boehringer Ingelheim GmbH,
Cipla, Inc., and Merck & Co., Inc.
Grand View Research has segmented the API market by type of synthesis,
type of manufacturer, type, applications, and region:
API Type of Synthesis Outlook (Revenue, USD
Billion, 2014 - 2025)
·
Biotech
o
Monoclonal
antibodies
o
Recombinant
proteins
o
Vaccines
·
Synthetic
API Type of Manufacturer Outlook (Revenue, USD
Billion, 2014 - 2025)
·
Captive APIs
·
Merchant APIs
API Type Outlook (Revenue, USD Billion, 2014 -
2025)
·
Generic APIs
·
Innovative
APIs
API Application Outlook (Revenue, USD Billion,
2014 - 2025)
·
Cardiovascular
Disease
·
Oncology
·
CNS &
Neurological Disorders
·
Orthopedic
Disorders
·
Endocrinology
·
Pulmonology
·
Gastrointestinal
Disorders
·
Nephrology
·
Ophthalmology
API Regional Outlook (Revenue, USD Billion,
2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Mexico
o
Brazil
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more market analysis reports, please
visit: http://www.grandviewresearch.com/
No comments:
Post a Comment